Clinical Trial Update: A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye [Phase 2]

View source ↗

Summary

Phase 2 study evaluating AL-38583 ophthalmic solution at 0.05% and 0.010% versus vehicle for dry eye has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• AL-38583 Ophthalmic Solution 0.010% (AL-38583)
• AL-38583 Ophthalmic Solution 0.05% (AL-38583)

Snippet

Sponsor: Alcon Research | Conditions: Dry Eye | Phase 2 | Status: COMPLETED